iA Global Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18K Sell
86
-10,911
-99% -$2.14M ﹤0.01% 456
2026
Q1
$2.15M Sell
10,997
-454
-4% -$88.2K 0.03% 266
2025
Q4
$1.99M Buy
11,451
+11,365
+13,215% +$2.07M 0.03% 265
2025
Q3
$16K Hold
86
– – ﹤0.01% 399
2025
Q2
$15K Buy
+86
New +$14.9K ﹤0.01% 413
2024
Q4
– Sell
-7,518
Closed -$1.17M – 448
2024
Q3
$1.17M Buy
+7,518
New +$1.12M 0.02% 316
2024
Q2
– Sell
-1,913
Closed -$255K – 486
2024
Q1
$255K Buy
+1,913
New +$248K 0.01% 415
2023
Q4
– Sell
-1,990
Closed -$243K – 471
2023
Q3
$243K Buy
+1,990
New +$265K 0.01% 414

Other funds holding DGX

iA Global Asset Management's DGX Position: Q2 2026 in Review

iA Global Asset Management reduced its Quest Diagnostics (DGX) stake by 99% in Q2 2026, selling an estimated $2.14M and leaving 86 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

iA Global Asset Management first reported a position in DGX in Q3 2023 and has held it in 8 quarters since. The position peaked at $2.15M in Q1 2026. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • iA Global Asset Management held 86 shares of Quest Diagnostics worth $18K as of Q2 2026.
  • iA Global Asset Management sold 10,911 Quest Diagnostics shares in Q2 2026, an estimated $2.14M.
  • Quest Diagnostics made up ﹤0.01% of iA Global Asset Management's portfolio in Q2 2026, its #456 holding.
  • iA Global Asset Management first reported a position in Quest Diagnostics in Q3 2023 and has held it in 8 quarters since.
  • iA Global Asset Management's Quest Diagnostics position peaked at $2.15M in Q1 2026.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.